HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ludmiła Weglarz Selected Research

Phytic Acid (Inositol Hexaphosphate)

3/2013Induction of the expression of genes encoding TGF-beta isoforms and their receptors by inositol hexaphosphate in human colon cancer cells.
11/2012Impact of celecoxib on soluble intercellular adhesion molecule-1 and soluble e-cadherin concentrations in human colon cancer cell line cultures exposed to phytic acid and TNF-alpha.
11/2012The influence of TNF-alpha on concentration of soluble adhesion molecules in cultures of HT-29 cells exposed to inositol hexaphosphate.
11/2012Inhibitory effect of inositol hexaphosphate on metalloproteinases transcription in colon cancer cells stimulated with phorbol-12-myristate 13-acetate.
11/2010Transcriptional regulation of interleukin 6 and its receptor in colon cancer cells by phytic acid.
11/2010Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid.
11/2008Evaluation of the expression of transcriptional factor NF-kappaB induced by phytic acid in colon cancer cells.
1/2008The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells.
1/2006Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate.
12/2004Application of HPLC for determination of phytic acid in the colonic epithelial Caco-2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ludmiła Weglarz Research Topics

Disease

12Colonic Neoplasms (Colon Cancer)
03/2013 - 03/2003
9Neoplasms (Cancer)
03/2013 - 12/2004
4Colorectal Neoplasms (Colorectal Cancer)
03/2013 - 11/2008
3Inflammation (Inflammations)
03/2013 - 01/2007
3Infections
01/2010 - 01/2007
3Ulcerative Colitis
12/2004 - 03/2003
2Neoplasm Metastasis (Metastasis)
11/2012 - 11/2012
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2004 - 03/2003
2Asthma (Bronchial Asthma)
01/2004 - 01/2003
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
11/2010
1Hypertrophy
11/2010
1Atherosclerosis
01/2010
1Occupational Diseases (Occupational Disease)
01/2008
1Hypersensitivity (Allergy)
01/2008
1Contact Dermatitis (Eczema, Contact)
01/2008
1Crohn Disease (Crohn's Disease)
12/2004

Drug/Important Bio-Agent (IBA)

10Phytic Acid (Inositol Hexaphosphate)IBA
03/2013 - 12/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2012 - 01/2008
3CytokinesIBA
11/2012 - 01/2010
3Interleukin-6 (Interleukin 6)IBA
11/2010 - 01/2007
2Metalloproteases (Metalloproteinases)IBA
11/2012 - 11/2010
2Tissue Inhibitor of Metalloproteinase-1IBA
11/2012 - 11/2010
2Inositol (Myoinositol)IBA
11/2012 - 11/2008
2Messenger RNA (mRNA)IBA
11/2010 - 01/2006
2Butyrates (Butyrate)IBA
07/2010 - 03/2005
2Butyric Acid (Butanoic Acid)IBA
03/2005 - 03/2003
2Pharmaceutical PreparationsIBA
12/2004 - 03/2003
2Bronchodilator Agents (Bronchodilators)IBA
01/2004 - 01/2003
1Transforming Growth Factor beta3 (TGF beta 3)IBA
03/2013
1Transforming Growth Factor beta2IBA
03/2013
1Transforming Growth Factor beta (TGF-beta)IBA
03/2013
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2013
1Protein Isoforms (Isoforms)IBA
03/2013
1AntipyreticsIBA
11/2012
1Celecoxib (Celebrex)FDA Link
11/2012
1Analgesics (Analgesic Drugs)IBA
11/2012
1Antineoplastic Agents (Antineoplastics)IBA
11/2012
1AntioxidantsIBA
11/2012
1CarcinogensIBA
11/2012
1CollagenIBA
11/2012
1Cadherins (E-Cadherin)IBA
11/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2012
1Matrix Metalloproteinases (MMPs)IBA
11/2012
1Therapeutic UsesIBA
11/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2012
1phorbol-12-myristateIBA
11/2012
1Tissue Inhibitor of Metalloproteinase-2IBA
11/2010
1Protein CIBA
11/2010
1Troponin T (Troponin T1)IBA
11/2010
1Ventricular MyosinsIBA
11/2010
1Cardiac MyosinsIBA
11/2010
1TropomyosinIBA
11/2010
1LipopolysaccharidesIBA
07/2010
1DNA (Deoxyribonucleic Acid)IBA
01/2010
1NF-kappa B (NF-kB)IBA
11/2008
1NF-KappaB Inhibitor alphaIBA
11/2008
1Ointments (Pastes)IBA
01/2008
1Interleukin-8 (Interleukin 8)IBA
01/2007
1Lipid AIBA
01/2007
1Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2004
1Biological ProductsIBA
06/2004
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2004
1Mesalamine (Mesalazine)FDA LinkGeneric
03/2003
1Volatile Fatty AcidsIBA
03/2003
1SulfapyridineFDA Link
03/2003
1CarbohydratesIBA
03/2003
1Amino AcidsFDA Link
01/2003

Therapy/Procedure

1Aftercare (After-Treatment)
01/2006
1Therapeutics
03/2003